Life Sciences Tools and Services
Company Overview of BioPharma Services Inc.
BioPharma Services Inc., a contract research organization, conducts clinical research trials for pharmaceutical, biotechnology, and medical device companies in Europe, the United States, Canada, Australia, and the rest of the world. The company specializes in conducting bioequivalence studies for generic pharmaceutical companies, and phase I/IIa clinical trials. Its services include clinical trial research, bioequivalence studies, pharmacokinetic analysis, regulatory affairs, data management, quality assurance, project management, and statistical services. The company also provides protocol development and review, clinical execution of the protocol, partnering with bioanalytical laboratories...
4000 Weston Road
Toronto, ON M9L 3A2
Key Executives for BioPharma Services Inc.
Compensation as of Fiscal Year 2017.
BioPharma Services Inc. Key Developments
Biopharma Services, Inc. Completes 3 FDA Inspections with Zero Form 483’s
May 26 17
BioPharma Services Inc. announced that it has successfully completed 3 inspections this month by the US FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri. Over the course of 2 weeks, the back-to-back inspections focused on a total of 9 studies including 4 bioanalytical validations that were conducted in support of ANDA and NDA filings to the US FDA. All 3 inspections concluded without a 483 Form being issued as BioPharma continues to build on its impressive regulatory track history with zero observations. BioPharma’s US-based clinical facility in Columbia, MO, underwent 2 sequential FDA inspections with impressive results. Since the opening in 2014, the US-based clinical site has completed a number of pivotal programs to support drug submissions to the US FDA and is poised to undergo a clinical expansion to 120-beds this summer. Following these 3 inspections across both sites, no Form 483s were issued, once again demonstrating BioPharma’s excellence and dedication to quality research. All 3 inspections were hosted and led by BioPharma’s Sr. Management Team, Andjica Tasic, VP of Global Quality Assurance and Regulatory Affairs, Louis Co, VP of Global Clinical Operations and Dr. Nicki Hughes, VP of Bioanalytical Operations. Under their leadership and direction, BioPharma continues to lead the industry in quality, innovation, and cost effectiveness.
BioPharma Services Inc. Announces Brent Matthews as New COO
Oct 30 15
BioPharma Services Inc. (BPSI) announced that Brent Matthews has joined the company in the role of Chief Operating Officer. Brent brings to BioPharma extensive knowledge and experience in the areas of clinical and laboratory operations ranging from R&D, Bioanalytical Services, Quality Control and Quality Assurance and will provide operational leadership and support to the organization. Brent held senior roles including General Manager at Innopharm Inc., VP of Quality at Contract Pharmaceuticals Limited, Director of Bioanalytical Laboratory at Biovail, as well as Senior Manager R&D Compliance at Teva. Brent's management style includes focused mentoring and coaching techniques and real life application of extensive experience in process improvement and Lean.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|